 PALO ALTO, Calif., April 13, 2021 GLOBE NEWSWIRE -- BridgeBio Pharma, Inc. NASDAQ: BBIO today announced a collaboration with Oregon Health Science University OHSU in Portland, Oregon, to advance research and the development of investigational medicines for patients with genetically driven conditions. 